slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 17,341-17,370
Pages 1,349
Rows per page 30
Beat
17,341-17,370 of 40,452
07
The table includes a 'June YTD' column header, indicating the 1H period.Salvatore Ferragamo | Results Presentation Deck | 10 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · EvidenceLoop · So What Cascade1 hit
15
The chart uses bubble size to represent market value in billions of dollars.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank Beat · Market Sizing1 hit
18
The slide uses a flow diagram to illustrate the conversion of two $0.60 entry fees into a $1.20 GMV, followed by a waterfall-style deduction to arrive at a $0.04 contribution.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank Beat · Business Model1 hit
16
Includes a biological pathway diagram and a clinical progression timeline.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
17
The chart uses a sigmoid-like curve to show the relationship between enzyme activity and disease progression.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
18
The vector uses a P2A self-cleaving linker to ensure 1:1 expression of the two genes under a single promoter.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
19
The chart uses standard statistical significance markers (*, **, ****) to denote p-values against the control group.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
20
The chart displays longitudinal data for five groups: Heterozygote/Vehicle, three dose levels of TSHA-101 in Knockout mice, and Knockout/Vehicle control.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
21
The chart displays statistical significance markers (asterisks) comparing treatment groups to the vehicle control.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
22
The slide uses a table-like structure to define the parameters of a Phase 1/2 clinical trial.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
23
Includes a diagram of the AAV9-hCLN1 gene therapy construct.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
24
The chart is a standard Kaplan-Meier survival plot used in preclinical efficacy studies.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
25
The chart compares untreated WT, Het, and KO mice against treated mice at 4, 20, and 26 weeks of age.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
26
The slide uses a consistent icon for each pipeline entry.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
27
The background features a DNA gel electrophoresis image, suggesting a biotech or genetic focus.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
28
Includes a citation for disease reversibility research.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Aha Moment1 hit
29
Includes a visual spectrum diagram showing the relationship between MECP2 expression levels and clinical outcomes.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Aha Moment1 hit
30
The slide uses a diagram to illustrate the genetic construct (scAAV ITR, MeP426, miniMECP2, miRARE).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Aha Moment1 hit
13
Teladoc | Mergers and Acquisitions Presentation Deck | 36 slidesTeladoc | Mergers and Acquisitions Presentation Deck | 36 slides · Teladoc Health
Conference presentation Investment bank Beat · Evidence & Proof1 hit
14
The slide uses a bar chart to visualize the TAM components, with supporting metrics for each segment below the bars.Teladoc | Mergers and Acquisitions Presentation Deck | 36 slides · Teladoc Health
Conference presentation Investment bank Beat · Evidence & Proof1 hit
15
The diagram uses a hub-and-spoke model to represent integrated care services.Teladoc | Mergers and Acquisitions Presentation Deck | 36 slides · Teladoc Health
Conference presentation Investment bank Beat · Evidence & Proof1 hit
16
The slide uses a winding path to show the progression of care, color-coded by service provider (Teladoc vs Livongo).Teladoc | Mergers and Acquisitions Presentation Deck | 36 slides · Teladoc Health
Conference presentation Investment bank Beat · Evidence & Proof1 hit
05
Tesla | Investor Day Presentation Deck | 74 slidesTesla | Investor Day Presentation Deck | 74 slides · Tesla
Conference presentation Investor relations Beat · Desire1 hit
06
The chart uses a stacked bar representation to illustrate the 100x growth requirement.Tesla | Investor Day Presentation Deck | 74 slides · Tesla
Conference presentation Investor relations Beat · Desire1 hit
07
The slide uses a visual comparison between a tiny 2019 baseline and a large 10 TWh target, broken down by sector demand.Tesla | Investor Day Presentation Deck | 74 slides · Tesla
Conference presentation Investor relations Beat · Desire1 hit
15
Unilever | Investor Conference Presentation Deck | 35 slidesUnilever | Investor Conference Presentation Deck | 35 slides · Unilever
Conference presentation Investor relations Beat · Evidence & Proof1 hit
16
The slide uses a split-screen illustration style (left: lab/science, right: wind energy/sustainability) with a central circular callout.Unilever | Investor Conference Presentation Deck | 35 slides · Unilever
Conference presentation Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
17
The slide uses circular image crops to display product photography.Unilever | Investor Conference Presentation Deck | 35 slides · Unilever
Conference presentation Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
18
The slide highlights the global footprint of the R&D organization, emphasizing sustainability, technology, and local agility.Unilever | Investor Conference Presentation Deck | 35 slides · Unilever
Conference presentation Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
19
Unilever | Investor Conference Presentation Deck | 35 slidesUnilever | Investor Conference Presentation Deck | 35 slides · Unilever
Conference presentation Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit